Condition
Stage IA Breast Cancer AJCC v7
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 22 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
22 shownMulticenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic TherapyNCT02945579 · 2017-01-20
RECRUITINGPatient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy AdherenceNCT04054557 · 2019-07-31
COMPLETEDSCOUT Reflector for Tagging Lymph Nodes for Targeted Removal in Patients With Breast CancerNCT03411070 · 2019-04-07
COMPLETEDGinseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer SurvivorsNCT03407716 · 2019-03-01
COMPLETEDPhase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast SurgeryNCT03317405 · 2018-10-31
ACTIVE_NOT_RECRUITINGThe Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast CancerNCT03454529 · 2018-03-09
COMPLETEDHypofractionated Radiation Therapy in Preventing Recurrence in Patients With Breast Cancer After SurgeryNCT03324802 · 2018-02-07
COMPLETEDKindness Interventions in Enhancing Well-Being in Breast Cancer SurvivorsNCT03319342 · 2017-07-11
COMPLETEDHypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast CancerNCT03077841 · 2017-03-06
SUSPENDEDHypofractionated vs. Conventional Regional Nodal Radiation Therapy for Patients With Invasive Breast CancerNCT02912312 · 2017-02-23
ACTIVE_NOT_RECRUITINGAlternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast CancerNCT02598557 · 2016-12-06
COMPLETEDWomen's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBCNCT02593175 · 2016-11-03
COMPLETEDEnzalutamide and Paclitaxel Before Surgery in Treating Patients With Stage I-III Androgen Receptor-Positive Triple-Negative Breast CancerNCT02689427 · 2016-09-22
COMPLETEDElectroacupuncture Therapy in Reducing Chronic Pain in Patients After Breast Cancer TreatmentNCT02754752 · 2016-09-13
ACTIVE_NOT_RECRUITINGCyclophosphamide, Paclitaxel, and Trastuzumab in Treating Stage I-II HER2/Neu Positive Breast Cancer After SurgeryNCT02654119 · 2015-12-11
COMPLETEDMolecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot InitiativeNCT02276443 · 2015-11-09
ACTIVE_NOT_RECRUITINGSensorimotor Rehabilitation Program in Improving Quality of Life in Patients With Early Stage Breast CancerNCT03568526 · 2015-07-02
COMPLETEDChemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast CancerNCT01275677 · 2011-02-08
COMPLETEDHypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast CancerNCT01266642 · 2011-02-08
ACTIVE_NOT_RECRUITINGRadiation Therapy in Treating Patients With Stage 0-II Breast CancerNCT01245712 · 2010-11-15
ACTIVE_NOT_RECRUITINGHormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)NCT00310180 · 2006-04-07
ACTIVE_NOT_RECRUITINGDoxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast CancerNCT00005970 · 2000-05-19
COMPLETEDCommon interventions
Laboratory Biomarker AnalysisOTHER14Quality-of-Life AssessmentOTHER11Questionnaire AdministrationOTHER11PaclitaxelDRUG5CyclophosphamideDRUG3Hypofractionated Radiation TherapyRADIATION3Radiation TherapyRADIATION3Therapeutic Conventional SurgeryPROCEDURE3TrastuzumabBIOLOGICAL3Behavioral InterventionBEHAVIORAL2Doxorubicin HydrochlorideDRUG2Educational InterventionOTHER2ExemestaneDRUG2Lymph Node BiopsyPROCEDURE2Partial Breast IrradiationRADIATION2Placebo AdministrationOTHER2Survey AdministrationOTHER2Tamoxifen CitrateDRUG2Accelerated Partial Breast IrradiationRADIATION1American GinsengDRUG1AnastrozoleDRUG1Aromatase Inhibition TherapyDRUG1Axillary Lymph Node DissectionPROCEDURE1Best PracticeOTHER1CarboplatinDRUG1
Leading sponsors
Trial status mix
COMPLETED13
ACTIVE_NOT_RECRUITING7
RECRUITING1
SUSPENDED1
Phase mix
PHASE210
NA5
PHASE35
EARLY_PHASE12
PHASE11
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.